Inicio>>Signaling Pathways>> Membrane Transporter/Ion Channel>> Calcium Channel>>Tiapamil hydrochloride (Ro 11-1781)

Tiapamil hydrochloride (Ro 11-1781)

Catalog No.GC32549

El clorhidrato de tiapamilo (Ro 11-1781) es un bloqueador de los canales de calcio.

Products are for research use only. Not for human use. We do not sell to patients.

Tiapamil hydrochloride (Ro 11-1781) Chemical Structure

Cas No.: 57010-32-9

Tamaño Precio Disponibilidad Cantidad
1mg
368,00 $
Disponible
5mg
735,00 $
Disponible
10mg
1.250,00 $
Disponible
20mg
2.206,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Tiapamil hydrochloride is a calcium channel blocker.

Tiapamil, a new calcium antagonist: hemodynamic effects in patients with acute myocardial infarction. Tiapamil is a new verapamil congener.Without precipitating left ventricular failure, Tiapamil reduced afterload and heart rate and maintained cardiac index while apparently improving diastolic compliance[1]. Tiapamil, a new calcium channel blocking agent with anti-anginal efficacy[2].

[1]. Eichler HG, et al. Tiapamil, a new calcium antagonist: hemodynamic effects in patients with acute myocardial infarction. Circulation. 1985 Apr;71(4):779-86. [2]. Khurmi NS, et al. Tiapamil, a new calcium channel blocking agent for the treatment of effort induced chronic stableangina pectoris.

Reseñas

Review for Tiapamil hydrochloride (Ro 11-1781)

Average Rating: 5 ★★★★★ (Based on Reviews and 40 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tiapamil hydrochloride (Ro 11-1781)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.